Published in Clin Orthop Relat Res on August 01, 2006
Correlation between avascular necrosis and the presence of the ossific nucleus when treating developmental dysplasia of the hip. J Child Orthop (2013) 0.84
Retrospective observational study comparing the international hip dysplasia institute classification with the Tonnis classification of developmental dysplasia of the hip. Medicine (Baltimore) (2017) 0.75
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology (2008) 3.47
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst (2005) 3.26
Clinicians and patients' welfare: where does academic freedom fit in? BMJ (2004) 2.63
End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst (2011) 2.14
The half-cycle correction revisited: redemption of a kludge. Med Decis Making (2013) 2.11
Modelling mitigation strategies for pandemic (H1N1) 2009. CMAJ (2009) 2.01
Preferences of husbands and wives for outcomes of prostate cancer screening and treatment. J Gen Intern Med (2004) 1.81
Is there an optimal comorbidity index for prostate cancer? Cancer (2008) 1.80
Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol (2003) 1.70
Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology (2013) 1.63
Reliability of Bucholz and Ogden classification for osteonecrosis secondary to developmental dysplasia of the hip. Clin Orthop Relat Res (2012) 1.46
Outcome at forty-five years after open reduction and innominate osteotomy for late-presenting developmental dislocation of the hip. J Bone Joint Surg Am (2007) 1.45
Marking the operative site: a lesson learned. CMAJ (2010) 1.41
Systematic review, critical appraisal, and analysis of the quality of economic evaluations in stroke imaging. Stroke (2014) 1.39
Is there age bias in the treatment of localized prostate carcinoma? Cancer (2004) 1.29
Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. Can J Urol (2003) 1.17
Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection. J Gastroenterol Hepatol (2012) 1.13
Kidney transplantation in the elderly: a decision analysis. J Am Soc Nephrol (2003) 1.13
A Canadian national survey of attitudes and knowledge regarding preventive vaccines. J Immune Based Ther Vaccines (2003) 1.11
Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. Am J Gastroenterol (2009) 1.10
Effect of innominate and femoral varus derotation osteotomy on acetabular development in developmental dysplasia of the hip. J Bone Joint Surg Am (2009) 1.08
How well do guidelines incorporate evidence on patient preferences? J Gen Intern Med (2009) 1.08
A review and meta-analysis of prostate cancer utilities. Med Decis Making (2007) 1.03
Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009. PLoS One (2012) 1.02
Continued undertreatment of older men with localized prostate cancer. Urology (2003) 0.99
Functional outcomes in children with osteonecrosis secondary to treatment of developmental dysplasia of the hip. J Bone Joint Surg Am (2011) 0.98
The presence of an ossific nucleus does not protect against osteonecrosis after treatment of developmental dysplasia of the hip. Clin Orthop Relat Res (2011) 0.96
Standardized diagnostic criteria for developmental dysplasia of the hip in early infancy. Clin Orthop Relat Res (2011) 0.94
Cost-utility analysis of primary prophylaxis versus secondary prophylaxis with granulocyte colony-stimulating factor in elderly patients with diffuse aggressive lymphoma receiving curative-intent chemotherapy. J Clin Oncol (2012) 0.92
How are dysplastic hips different? A three-dimensional CT study. Clin Orthop Relat Res (2014) 0.91
Factors associated with the high cost of liver transplantation in adults. Can J Surg (2002) 0.88
The health and quality of life outcomes among youth and young adults with cerebral palsy. Arch Phys Med Rehabil (2010) 0.88
Health status utilities and the impact of pressure ulcers in long-term care residents in Ontario. Qual Life Res (2009) 0.88
Does cirrhosis affect quality of life in hepatitis C virus-infected patients? Liver Int (2009) 0.84
Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A. BMC Infect Dis (2006) 0.83
Health-state utilities in a prisoner population: a cross-sectional survey. Health Qual Life Outcomes (2009) 0.83
Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Am J Med Genet A (2005) 0.82
Youth and young adults with cerebral palsy: their use of physician and hospital services. Arch Phys Med Rehabil (2007) 0.82
A Reliable and Valid Objective Structured Assessment of Technical Skill for the Application of a Pavlik Harness Based on International Expert Consensus. J Pediatr Orthop (2016) 0.82
Femoral varus derotation osteotomy for the treatment of habitual subluxation and dislocation of the pediatric hip in trisomy 21: a 10-year experience. J Pediatr Orthop (2011) 0.82
Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework. Med Decis Making (2010) 0.82
An incomplete periacetabular osteotomy for treatment of neuromuscular hip dysplasia. Clin Orthop Relat Res (2005) 0.81
Marker states and a health state prompt provide modest improvements in the reliability and validity of the standard gamble and rating scale in prostate cancer patients. Qual Life Res (2007) 0.81
Radiographic results of combined Salter innominate and femoral osteotomy in Legg-Calvé-Perthes disease in older children. J Child Orthop (2009) 0.81
An unadjusted NNT was a moderately good predictor of health benefit. J Clin Epidemiol (2006) 0.81
Guidelines for health technologies: specific guidance for oncology products in Canada. Value Health (2012) 0.80
Techniques for estimating health care costs with censored data: an overview for the health services researcher. Clinicoecon Outcomes Res (2012) 0.79
Concordance of couples' prostate cancer screening recommendations from a decision analysis. Patient (2008) 0.78
Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn's disease? A Markov analysis. Dis Colon Rectum (2004) 0.78
How much are we spending? The estimation of research expenditures on cardiovascular disease in Canada. BMC Health Serv Res (2012) 0.78
Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis. Can J Gastroenterol (2007) 0.78
Patient time costs and out-of-pocket costs in hepatitis C. Liver Int (2012) 0.78
Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS). Med Decis Making (2011) 0.78
Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis. Breast Cancer Res Treat (2015) 0.78
Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients. Can J Gastroenterol (2006) 0.77
Medical therapy v. PCI in stable coronary artery disease: a cost-effectiveness analysis. Med Decis Making (2013) 0.77
Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, Canada. J Cancer Surviv (2013) 0.77
Response to "the life table method of half-cycle correction: getting it right". Med Decis Making (2014) 0.76
Rethinking 30-day mortality risk after radical prostatectomy. Urology (2006) 0.76
Canada's contribution to global research in cardiovascular diseases. Can J Cardiol (2012) 0.76
Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative. Clinicoecon Outcomes Res (2012) 0.75
Economics of preventing premature mortality and impaired cognitive development in children through home-fortification: a health policy perspective. Int J Technol Assess Health Care (2008) 0.75
Management of hip instability in trisomy 21. J Pediatr Orthop (2013) 0.75
The association between patient age and prostate cancer stage and grade at diagnosis. BJU Int (2004) 0.75